Form 4: Genpact Director Brian Mark Stevens Receives Equity Award of 4,825 Restricted Share Units

Genpact LTD Director Brian Mark Stevens was granted 4,825 unvested restricted share units (RSUs) on May 22, 2025, as part of the company's incentive compensation plan.

Summary

• Brian Mark Stevens, a Director of Genpact LTD (G), was granted 4,825 unvested restricted share units (RSUs) on May 22, 2025.
• These RSUs were awarded under the Genpact Limited 2017 Omnibus Incentive Compensation Plan.
• Each RSU entitles the holder to receive one common share of Genpact LTD.
• The RSUs are subject to the reporting person's continued service and will fully vest on December 31, 2025.
• The common shares resulting from the vested RSUs will be settled on December 31, 2026.
• Following this transaction, Brian Mark Stevens beneficially owns 30,098 common shares.

Sentiment

Score: 7

Explanation: The filing indicates a routine equity compensation grant to a director, which is generally viewed positively as it aligns management interests with shareholders and incentivizes long-term performance. There are no negative implications or surprises within this specific report.

Positives

• The grant of 4,825 restricted share units to Director Brian Mark Stevens aligns his interests with those of shareholders, incentivizing long-term performance and retention.
• This equity award is part of a standard incentive compensation plan, indicating a structured approach to executive remuneration.

Negatives

• No direct negatives are identified in this routine equity compensation filing.

Risks

• The RSUs are subject to forfeiture if the reporting person's continued service to the company is not maintained until the vesting date of December 31, 2025.

Future Outlook

The granted restricted share units are scheduled to fully vest on December 31, 2025, contingent on the director's continued service, with the common shares to be settled on December 31, 2026.

Industry Context

The grant of restricted share units to a director is a common practice in the corporate world, particularly within the technology and business process management sectors where Genpact operates. Such equity awards are standard components of executive and director compensation packages, designed to align leadership interests with long-term shareholder value creation.

Comparison to Industry Standards

• The use of Restricted Share Units (RSUs) as a form of equity compensation is a widely adopted practice across global industries, including professional services and IT consulting firms like Accenture, Cognizant, and Wipro, which often utilize similar long-term incentive plans for their directors and executives.
• The vesting schedule, tied to continued service, is typical for such awards, ensuring retention and commitment from key personnel.
• The specific number of units granted would typically be benchmarked against peer group compensation data, though this filing does not provide such comparative details.

Corporate Governance

Related Party Transactions

• The grant of 4,825 restricted share units to Brian Mark Stevens, a Director of Genpact LTD, constitutes a related party transaction as it involves compensation provided by the company to a member of its board of directors. This is a standard form of executive compensation under an existing incentive plan.

Stakeholder Impact

• Shareholders: The equity grant aims to align the director's long-term interests with shareholder value creation, potentially leading to improved company performance and stock appreciation.
• Employees: While not directly impacting general employees, such compensation practices for leadership can set a precedent for performance-based incentives within the company.

Next Steps

• Continued service of Brian Mark Stevens until December 31, 2025, for the RSUs to fully vest.
• Settlement of the vested RSUs into common shares on December 31, 2026.

Key Dates

Recommendation

Keywords

Genpact, G, Form 4, Restricted Share Units, RSU, Equity Compensation, Insider Transaction, Director, Stock Award, Incentive Plan